ValiRx plc (LON:VAL – Get Free Report)’s stock price crossed below its 200-day moving average during trading on Friday. The stock has a 200-day moving average of GBX 0.19 and traded as low as GBX 0.12. ValiRx shares last traded at GBX 0.12, with a volume of 1,472,860 shares changing hands.
ValiRx Trading Down 6.9%
The firm’s 50-day moving average price is GBX 0.14 and its two-hundred day moving average price is GBX 0.19. The stock has a market cap of £1.60 million, a PE ratio of -0.30 and a beta of 0.59.
ValiRx (LON:VAL – Get Free Report) last issued its quarterly earnings data on Tuesday, September 15th. The company reported GBX (0.09) earnings per share (EPS) for the quarter. ValiRx had a negative net margin of 6,548.06% and a negative return on equity of 71.49%. On average, analysts anticipate that ValiRx plc will post -1.74 earnings per share for the current year.
ValiRx Company Profile
ValiRx accelerates the development of treatments in cancer and women’s health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.
Recommended Stories
- Five stocks we like better than ValiRx
- Rocket Lab’s Neutron Delay Leaves Wall Street Bullish But Raises the Stakes for 2027
- ManpowerGroup Stock Sinks on Q3 Results, But Fundamentals Stay Solid
- Does the AI Selloff Put Alphabet’s Breakout in Doubt?
- Bank Earnings Are Mixed—These 2 ETFs Offer Very Different Paths to a Recovery
Receive News & Ratings for ValiRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ValiRx and related companies with MarketBeat.com's FREE daily email newsletter.
